{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T12:50:12Z","timestamp":1770814212375,"version":"3.50.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,1,2]],"date-time":"2021-01-02T00:00:00Z","timestamp":1609545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,2]],"date-time":"2021-01-02T00:00:00Z","timestamp":1609545600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s00415-020-10342-3","type":"journal-article","created":{"date-parts":[[2021,1,2]],"date-time":"2021-01-02T05:02:41Z","timestamp":1609563761000},"page":"1803-1807","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Acetylcholine receptor antibody positivity rate in ocular myasthenia gravis: a matter of age?"],"prefix":"10.1007","volume":"268","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4763-7784","authenticated-orcid":false,"given":"Gabriele","family":"Monte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregorio","family":"Spagni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Damato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaele","family":"Iorio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariapaola","family":"Marino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amelia","family":"Evoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,2]]},"reference":[{"issue":"1","key":"10342_CR1","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s11910-013-0421-9","volume":"14","author":"SH Wong","year":"2014","unstructured":"Wong SH, Huda S, Vincent A, Plant GT (2014) Ocular myasthenia gravis: controversies and updates. Curr Neurol Neurosci Rep 14(1):421. https:\/\/doi.org\/10.1007\/s11910-013-0421-9","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"10","key":"10342_CR2","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1001\/jamaneurol.2015.1444","volume":"72","author":"CE Peeler","year":"2015","unstructured":"Peeler CE, De Lott LB, Nagia L, Lemos J, Eggenberger ER, Cornblath WT (2015) Clinical utility of acetylcholine receptor antibody testing in ocular myasthenia gravis. JAMA Neurol 72(10):1170\u20131174. https:\/\/doi.org\/10.1001\/jamaneurol.2015.1444","journal-title":"JAMA Neurol"},{"key":"10342_CR3","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ajo.2019.04.017","volume":"205","author":"TM Hendricks","year":"2019","unstructured":"Hendricks TM, Bhatti MT, Hodge DO, Chen JJ (2019) Incidence, epidemiology, and transformation of ocular myasthenia gravis: a population-based study. Am J Ophthalmol 205:99\u2013105. https:\/\/doi.org\/10.1016\/j.ajo.2019.04.017","journal-title":"Am J Ophthalmol"},{"issue":"1\u20132","key":"10342_CR4","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1159\/000500268","volume":"53","author":"P Maddison","year":"2019","unstructured":"Maddison P, Ambrose PA, Sadalage G, Vincent A (2019) A prospective study of the incidence of myasthenia gravis in the East Midlands of England. Neuroepidemiology 53(1\u20132):93\u201399. https:\/\/doi.org\/10.1159\/000500268","journal-title":"Neuroepidemiology"},{"issue":"11","key":"10342_CR5","doi-asserted-by":"publisher","first-page":"e1171","DOI":"10.1212\/wnl.0000000000008903","volume":"94","author":"E Cort\u00e9s-Vicente","year":"2020","unstructured":"Cort\u00e9s-Vicente E, \u00c1lvarez-Velasco R, Segovia S et al (2020) Clinical and therapeutic features of myasthenia gravis in adults based on age at onset. Neurology 94(11):e1171\u2013e1180. https:\/\/doi.org\/10.1212\/wnl.0000000000008903","journal-title":"Neurology"},{"issue":"1","key":"10342_CR6","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/0090-1229(77)90027-7","volume":"7","author":"J Lindstrom","year":"1977","unstructured":"Lindstrom J (1977) An assay for antibodies to human acetylcholine receptor in serum from patients with Myasthenia Gravis. Clin Immunol Immunopathol 7(1):36\u201343. https:\/\/doi.org\/10.1016\/0090-1229(77)90027-7","journal-title":"Clin Immunol Immunopathol"},{"key":"10342_CR7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/bf00313202","volume":"224","author":"E Bartoccioni","year":"1980","unstructured":"Bartoccioni E, Scuderi F, Scoppetta C et al (1980) Myasthenia gravis, thymectomy, and antiacetycholine receptor antibody. J Neurol 224:9\u201315. https:\/\/doi.org\/10.1007\/bf00313202","journal-title":"J Neurol"},{"key":"10342_CR8","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1097\/cnd.0b013e31821c5634","volume":"13","author":"MK Mittal","year":"2011","unstructured":"Mittal MK, Barohn RJ, Pasnoor M, McVey A, Herbelin L, Whittaker T, Dimachkie M et al (2011S) Ocular myasthenia gravis in an academic neuro-ophthalmology clinic: clinical features and therapeutic response. J Clin Neuromuscul Dis 13:46\u201352. https:\/\/doi.org\/10.1097\/cnd.0b013e31821c5634","journal-title":"J Clin Neuromuscul Dis"},{"key":"10342_CR9","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ensci.2016.04.005","volume":"4","author":"A Karni","year":"2016","unstructured":"Karni A, Asmail A, Drory VE, Kolb H, Kesleret A (2016) Characterization of patients with ocular myasthenia gravis\u2014a case series. eNeurologicalSci 4:30\u201333. https:\/\/doi.org\/10.1016\/j.ensci.2016.04.005","journal-title":"eNeurologicalSci"},{"key":"10342_CR10","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/ane.13239","volume":"142","author":"I Lotan","year":"2020","unstructured":"Lotan I, Benninger F, Hellmann MA, Sicsic C, Brenner T, Kahana E, Steiner I (2020) Incidence of AChR Ab-positive myasthenia gravis in Israel: a population-based study. Acta Neurol Scand 142:66\u201373. https:\/\/doi.org\/10.1111\/ane.13239","journal-title":"Acta Neurol Scand"},{"key":"10342_CR11","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1136\/jnnp.56.5.496","volume":"56","author":"FE Somnier","year":"1993","unstructured":"Somnier FE (1993) Clinical implementation of anti-acetylcholine receptor antibodies. J Neurol Neurosurg Psychiatry 56:496\u2013504. https:\/\/doi.org\/10.1136\/jnnp.56.5.496","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10342_CR12","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1136\/jnnp.74.8.1105","volume":"74","author":"A Vincent","year":"2003","unstructured":"Vincent A, Clover L, Buckley C, Evans JG, Rothwell PM, UK Myasthenia Gravis Survey (2003) Evidence of underdiagnosis of myasthenia gravis in older people. J Neurol Neurosurg Psychiatry 74:1105\u20131108. https:\/\/doi.org\/10.1136\/jnnp.74.8.1105","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"10342_CR13","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1212\/01.wnl.0000176067.32186.a3","volume":"65","author":"FE Somnier","year":"2005","unstructured":"Somnier FE (2005) Increasing incidence of late-onset anti-AChR antibody-seropositive myasthenia gravis. Neurology 65(6):928\u2013930. https:\/\/doi.org\/10.1212\/01.wnl.0000176067.32186.a3","journal-title":"Neurology"},{"issue":"3","key":"10342_CR14","doi-asserted-by":"publisher","first-page":"352","DOI":"10.4103\/0028-3886.43455","volume":"56","author":"BS Singhal","year":"2008","unstructured":"Singhal BS, Bhatia NS, Umesh T, Menon S (2008) Myasthenia gravis: a study from India. Neurol India 56(3):352\u2013355. https:\/\/doi.org\/10.4103\/0028-3886.43455","journal-title":"Neurol India"},{"issue":"3","key":"10342_CR15","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1006\/clin.1995.1042","volume":"74","author":"PF Kennel","year":"1995","unstructured":"Kennel PF, Vilquin JT, Braun S, Fonteneau P, Warter JM, Poindron P (1995) Myasthenia gravis: comparative autoantibody assays using human muscle, TE671, and glucocorticoid-treated TE671 cells as sources of antigen. Clin Immunol Immunopathol 74(3):293\u2013296. https:\/\/doi.org\/10.1006\/clin.1995.1042","journal-title":"Clin Immunol Immunopathol"},{"issue":"12","key":"10342_CR16","doi-asserted-by":"publisher","first-page":"e114060","DOI":"10.1371\/journal.pone.0114060","volume":"9","author":"AT Heldal","year":"2014","unstructured":"Heldal AT, Eide GE, Romi F, Owe JF, Gilhus NE (2014) Repeated acetylcholine receptor antibody-concentrations and association to clinical myasthenia gravis development. PLoS ONE 9(12):e114060. https:\/\/doi.org\/10.1371\/journal.pone.0114060","journal-title":"PLoS ONE"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-020-10342-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-020-10342-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-020-10342-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,25]],"date-time":"2021-04-25T05:38:36Z","timestamp":1619329116000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-020-10342-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,2]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["10342"],"URL":"https:\/\/doi.org\/10.1007\/s00415-020-10342-3","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,2]]},"assertion":[{"value":"12 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"On behalf of all authors, the corresponding author states that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The study was approved by the Ethics Committee of Catholic University (protocol #26739\/13) and was performed in accordance with the Declaration of Helsinki and its later amendments. This study was deemed exempt from requiring patient consent, as it was a retrospective collection of existing, deidentified data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"All authors have read the final version of the manuscript and have agreed to be included in the list of authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Data are available from corresponding author upon request.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data"}}]}}